Regulatory Flexibility

·2013·DOI

Health Sciences and Innovation

Social Science Analytics

Materials Science and Analysis

Biopharmaceutical Innovation Economics

Role in the Field

Neutralin Health Sciences and Innovation

Neutralin Social Science Analytics

Neutralin Materials Science and Analysis

Neutralin Biopharmaceutical Innovation Economics

Abstract

Citations

1,069

Year

2013

PageRank

2.7 / 10

Relative influence (log-scaled)

Related Papers

10 of 10 papers

Innovation In The Pharmaceutical Industry: New Estimates Of R&D Costs

·2016·2,415 citations

Diagnosing The Decline In Pharmaceutical R&D Efficiency

·2012·1,607 citations

How To Improve R&D Productivity: The Pharmaceutical Industry'S Grand Challenge

·2010·2,877 citations

Metafrontier Frameworks For The Study Of Firm-Level Efficiencies And Technology Ratios

·2007·1,027 citations

Exploration And Exploitation Alliances In Biotechnology: A System Of New Product Development

·2004·1,335 citations

Don't Go It Alone: Alliance Network Composition And Startups' Performance In Canadian Biotechnology

·2000·1,783 citations

Can Patents Deter Innovation? The Anticommons In Biomedical Research

·1998·1,554 citations

Scale, Scope, And Spillovers: The Determinants Of Research Productivity In Drug Discovery

·1996·880 citations

Selection And The Evolution Of Industry

·1982·2,654 citations

Hybrid Corn: An Exploration In The Economics Of Technological Change

·1957·1,924 citations